-
New Drug Application Submission Initiated for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation NSCLC for Review Under FDA Real-Time Oncology Review Program
In the Phase 3 REZILIENT3 study, zipalertinib combination therapy demonstrated longest median progression-free
Lifestyle Content
Technology
-
Pompa Program By Dr Pompa Reached 4.9 Out Of 5 Stars On Trustpilot
-
Puremaxx Filtration Solutions Joins Brookaire Air Filters, Uniting Two Veteran-Founded HVAC Filtration Companies
-
Valiant Roofing Positions Roof Maintenance Planning as the Smartest Investment in Long-Term Home Protection
-
ABC Glass Company Takes $120 Off Custom Shower Enclosures as Phoenix Snowbirds Return
-
B.A.R.E. Essentials Spa Opens Medical Spa Location in Windsor to Serve Tecumseh and Surrounding Communities
Entertainment
-
Davis & The Love Announce New Album Songs We Wrote About You, Arriving October 16
-
The Empty Pockets Announce $285,000 “Billionaire Pricing” for Their New Album
-
Georgia’s Magical Nights of Lights Bigger and Brighter for 2026
-
Migguel Anggelo Celebrates the Immigrant Experience, Latino Identity, and the Power of Iconic Latin Rhythms During Hispanic Heritage Month
-
Pragmatic123 Expands Customer Support With 24/7 Live Chat
Health
-
Edmunds ranks the best SUVs for parents
-
Ontario is reviving its threat to cut electricity exports to the US. What does that mean?
-
How to get started with solo travel
-
6 key Dreamforce 2026 takeaways for the GTM tech stack
-
The metro areas with America’s worst commutes aren’t the ones with the worst insurance bills
